JULPHAR - Gulf Pharmaceutical Industries

 Home | New Investors | company results | Companies | UAE Brokers | Stock Forum | Latest posts | UAE news

Forum Topics
Recent News
Comments
Financial Reports
Contact and Links
          

Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com

Share prices in AED | Chart help
Interactive Stock Charts provided by WD SOFTWARE

Share price 15 Apr 2009 1.36 dhs
Price/earnings (annualised)
Latest report JULPHAR 2008 M9 report
Stock market Abu Dhabi Securities Exchange
Founding date 30 Mar 1980 Listing date 19 Oct 2002
Auditor Talal Abu-Ghazaleh & Co International
Chairman of JULPHAR Shaikh Faisal Bin Saqr Al Qasimi
CEO of JULPHAR Abdul Razzaq Yousef
Foreign ownership limit Maximum 49%
Total shares outstanding 641,042,000
Market capitalisation (AED) 871,817,120
Par value 1 Dh per share
Dividends for 2013 FY
Cash dividend yield
Fair Value estimate
Share price rating  
Difference from fair value
Consider buying below
Consider selling above
Latest share data for JULPHAR orders | trades | chart
Ratings, estimates, comments are opinions only, and are not to be taken as advice to buy, sell or hold shares. E&OE.
JULPHAR reports
* annualised
Date Profit
AED
EPS
AED
EPS*
AED
Price
AED
PE* PBV ROE* ROS
JULPHAR 2008 Q3 29 Oct 2008 10.4m 0.02 0.06 1.73 26.7 0.9 3.2% 7.4%
JULPHAR 2008 Q2 20 Jul 2008 79.5m 0.12 0.50 2.31 4.7 1.2 26.2%  
JULPHAR 2008 Q1 27 Apr 2008 42.7m 0.07 0.27 2.36 8.9 1.2 14.1% 27.2%
JULPHAR 2007 FY 03 Jan 2008 207m 0.34 0.34 2.63 7.8 1.4 18.4% 31.3%
JULPHAR 2007 Q3 29 Oct 2007 42.9m 0.07 0.28 2.08 7.4 1.1 15.2% 28.6%
JULPHAR 2007 Q2 30 Jul 2007 31.2m 0.05 0.20 1.98 9.7 1.1 11.5% 19.9%
JULPHAR 2007 Q1 19 Apr 2007 31.1m 0.06 0.24 2.71 11.2 1.6 14.1% 17.7%
JULPHAR 2006 FY 29 Jan 2007 66.7m 0.13 0.13 2.05 15.9 1.2 7.3% 10.9%
JULPHAR 2005 FY 117m           15.5% 21.5%
JULPHAR 2004 FY 67.1m              
Share price 15 Apr 2009 1.36 dhs
Price/earnings (annualised)
Latest report JULPHAR 2008 M9 report
Stock market Abu Dhabi Securities Exchange
Founding date 30 Mar 1980 Listing date 19 Oct 2002
Auditor Talal Abu-Ghazaleh & Co International
Chairman of JULPHAR Shaikh Faisal Bin Saqr Al Qasimi
CEO of JULPHAR Abdul Razzaq Yousef
Foreign ownership limit Maximum 49%
Total shares outstanding 641,042,000
Market capitalisation (AED) 871,817,120
Par value 1 Dh per share
Dividends for 2013 FY
Cash dividend yield
Fair Value estimate
Share price rating  
Difference from fair value
Consider buying below
Consider selling above
Latest share data for JULPHAR orders | trades | chart
Ratings, estimates, comments are opinions only, and are not to be taken as advice to buy, sell or hold shares. E&OE.
JULPHAR reports
* annualised
Date Profit
AED
EPS
AED
EPS*
AED
Price
AED
PE* PBV ROE* ROS
JULPHAR 2008 Q3 29 Oct 2008 10.4m 0.02 0.06 1.73 26.7 0.9 3.2% 7.4%
JULPHAR 2008 Q2 20 Jul 2008 79.5m 0.12 0.50 2.31 4.7 1.2 26.2%  
JULPHAR 2008 Q1 27 Apr 2008 42.7m 0.07 0.27 2.36 8.9 1.2 14.1% 27.2%
JULPHAR 2007 FY 03 Jan 2008 207m 0.34 0.34 2.63 7.8 1.4 18.4% 31.3%
JULPHAR 2007 Q3 29 Oct 2007 42.9m 0.07 0.28 2.08 7.4 1.1 15.2% 28.6%
JULPHAR 2007 Q2 30 Jul 2007 31.2m 0.05 0.20 1.98 9.7 1.1 11.5% 19.9%
JULPHAR 2007 Q1 19 Apr 2007 31.1m 0.06 0.24 2.71 11.2 1.6 14.1% 17.7%
JULPHAR 2006 FY 29 Jan 2007 66.7m 0.13 0.13 2.05 15.9 1.2 7.3% 10.9%
JULPHAR 2005 FY 117m           15.5% 21.5%
JULPHAR 2004 FY 67.1m              

JULPHAR opinion, news, reports, researchTop


Fatal error: Call to undefined function message_die() in /home/dubaisha/public_html/viewforum-sw.php on line 104

JULPHAR latest news (links open in new window)Top

News Item

Market Report, CountryFocus: Healthcare, Regulatory and Reimbursement ... DigitalJournal.com Boston, MA -- (SBWIRE) -- 07/23/2014 -- GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates . It is an essential source of information on and ... More ...


News Item

Human Insulin Market Worth $42 Billion by 2019 - New Report by ... Virtual-Strategy Magazine (press release) ... prevalence rate of diabetes as well as low price of human insulin. The key players in the market are Novo Nordisk (Denmark), Eli Lilly (U.S), Sanofi Aventis (France), Biocon (India), Julphar (U.A.E),Wockhardt (India),SemBioSys (Canada), and GSK (U.K.). More ...


News Item

UAE-Based Strata Signs $16.5m Deal With PCT For A380 Programme Gulf Business News Related Business News. Julphar Signs Insulin Deal With US-Based Firm; Spearheading The Space Agenda; Qatar Airways A380 Deliveries Delayed Again – CEO; Qatar Airways Delays Taking First A380 By Several Weeks ... and more » More ...


News Item

The National Pharmaceutical sector in the UAE is in good health The National Local production of medicines is done by eight companies in the UAE. These include Julphar , Neopharma, Globalpharma, and Medpharma. Besides supplying the domestic market, they export a share of their products to Middle East and North Africa and ... More ...


News Item

Zayed Humanitarian Day on Ramadan 19 gulfnews.com Abu Dhabi: In a tribute to the founding father of the UAE, Shaikh Zayed Bin Sultan Al Nahyan, several activities and charity works will be launched across the UAE on Ramadan 19, the Khalifa Bin Zayed Al Nahyan Foundation (KBZF) announced on Sunday in ... and more » More ...


News Item

Kenya ranks high in attracting foreign direct investment The Standard Digital News Early in the year, Julphar from United Arab Emirates, in conjunction with its local partner, Medtech, officially inaugurated its first pharmaceutical manufacturing facility in Addis Ababa. According to the report, Uganda, Tanzania and Madagascar maintained ... and more » More ...


News Item

Worldwide Human Insulin Market 2014-2018 Research Report Now Available at ... Virtual-Strategy Magazine (press release) Companies profiled in this human insulin market research report for 2014-2018 include Novo Nordisk, EliLilly, Sanofi Aventis, Biocon and Julphar Pharmaceuticals. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=291200. and more » More ...


News Item

The National Sanofi acquires stake in Globalpharma from Dubai Investments The National Also last month, Abu Dhabi's Neopharma announced a tie-up with the Pfizer's Wyeth to manufacture medicines for cardiovascular diseases, women's health and pain management. And in April, Julphar announced a five-year licensing agreement with MSD, ... and more » More ...


News Item

RAK Properties organises blood donation drive Construction Week Online RAK Properties PJSC teamed up with the Health Education and Communication Department in Ras Al Khaimah to successfully organise a blood donation at the Julphar Towers, in the heart of the city. Around 74 individuals participated in the bloodletting ... More ...


News Item

Report Indicated Ethiopia Attracted US $ 953 Million FDI in 2013 2merkato - Ethiopian Business Portal Another example stated was the joint venture formed by the Julphar , a UAE's company, and Medtech, a local company, for the purpose of constructing a pharmaceutical manufacturing facility in Ethiopia. The report further noted Julphar 's investment for the ... and more » More ...


Newsfeed from Google News. See also latest UAE market news.

JULPHAR opinion, news, reports, researchTop


Fatal error: Call to undefined function message_die() in /home/dubaisha/public_html/viewforum-sw.php on line 104
Julphar financial statements & accountsTop
PDF files (new window) 2004 2005 2006 2007 2008
JULPHAR First Quarter 2004Q1 2005Q1 2006Q1 2007Q1 2008Q1
JULPHAR Second Quarter 2004Q2 2005Q2 2006Q2 2007Q2 2008Q2
JULPHAR Third Quarter 2004Q3 2005Q3 2006Q3 2007Q3  2008Q3
JULPHAR Preliminary FY Report 2004PR 2005PR 2006PR  2007PR   
JULPHAR Final Annual Report 2004FY 2005FY 2006FY 2007FY

Links are to the relevant PDF report on the ESCA website and are provided as a convenience by ShareWadi.com. We are not responsible for the content or availability of any external sites or pages. If accounts are not available from ESCA, try the ADX or DFM website.

JULPHAR latest news (links open in new window)Top

News Item

Market Report, CountryFocus: Healthcare, Regulatory and Reimbursement ... DigitalJournal.com Boston, MA -- (SBWIRE) -- 07/23/2014 -- GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates . It is an essential source of information on and ... More ...


News Item

Human Insulin Market Worth $42 Billion by 2019 - New Report by ... Virtual-Strategy Magazine (press release) ... prevalence rate of diabetes as well as low price of human insulin. The key players in the market are Novo Nordisk (Denmark), Eli Lilly (U.S), Sanofi Aventis (France), Biocon (India), Julphar (U.A.E),Wockhardt (India),SemBioSys (Canada), and GSK (U.K.). More ...


News Item

UAE-Based Strata Signs $16.5m Deal With PCT For A380 Programme Gulf Business News Related Business News. Julphar Signs Insulin Deal With US-Based Firm; Spearheading The Space Agenda; Qatar Airways A380 Deliveries Delayed Again – CEO; Qatar Airways Delays Taking First A380 By Several Weeks ... and more » More ...


News Item

The National Pharmaceutical sector in the UAE is in good health The National Local production of medicines is done by eight companies in the UAE. These include Julphar , Neopharma, Globalpharma, and Medpharma. Besides supplying the domestic market, they export a share of their products to Middle East and North Africa and ... More ...


News Item

Zayed Humanitarian Day on Ramadan 19 gulfnews.com Abu Dhabi: In a tribute to the founding father of the UAE, Shaikh Zayed Bin Sultan Al Nahyan, several activities and charity works will be launched across the UAE on Ramadan 19, the Khalifa Bin Zayed Al Nahyan Foundation (KBZF) announced on Sunday in ... and more » More ...


News Item

Kenya ranks high in attracting foreign direct investment The Standard Digital News Early in the year, Julphar from United Arab Emirates, in conjunction with its local partner, Medtech, officially inaugurated its first pharmaceutical manufacturing facility in Addis Ababa. According to the report, Uganda, Tanzania and Madagascar maintained ... and more » More ...


News Item

Worldwide Human Insulin Market 2014-2018 Research Report Now Available at ... Virtual-Strategy Magazine (press release) Companies profiled in this human insulin market research report for 2014-2018 include Novo Nordisk, EliLilly, Sanofi Aventis, Biocon and Julphar Pharmaceuticals. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=291200. and more » More ...


News Item

The National Sanofi acquires stake in Globalpharma from Dubai Investments The National Also last month, Abu Dhabi's Neopharma announced a tie-up with the Pfizer's Wyeth to manufacture medicines for cardiovascular diseases, women's health and pain management. And in April, Julphar announced a five-year licensing agreement with MSD, ... and more » More ...


News Item

RAK Properties organises blood donation drive Construction Week Online RAK Properties PJSC teamed up with the Health Education and Communication Department in Ras Al Khaimah to successfully organise a blood donation at the Julphar Towers, in the heart of the city. Around 74 individuals participated in the bloodletting ... More ...


News Item

Report Indicated Ethiopia Attracted US $ 953 Million FDI in 2013 2merkato - Ethiopian Business Portal Another example stated was the joint venture formed by the Julphar , a UAE's company, and Medtech, a local company, for the purpose of constructing a pharmaceutical manufacturing facility in Ethiopia. The report further noted Julphar 's investment for the ... and more » More ...


Newsfeed from Google News. See also latest UAE market news.

Julphar comments & notesTop

Gulf Pharmaceuticals is a cosmetic, drugs, and medicine manufacturing company. Although it was incorporated at the end of March 1980, it did not start commercial operations until November 1984.

Subsidiaries and stakes in other companies

  • Awafi Drug Store - direct sales of pharmaceuticals (sold to Planet Pharmacies in Dec 2007)
  • Julphar Drug Stores, UAE - distribution network for Julphar products (sold to Planet Pharmacies in Dec 2007)
  • Julphar Pharmacies, UAE - direct selling of Julphar drugs and cosmetics
  • Julphar Pharma Factory, Germany - production facility for medical and pharmaceutical cosmetics
  • Planet Pharmacies, Dubai, UAE (40%) - chain of retail outlets, JV with Global Investment House
  • Scientific Pharmacy, Oman - distribution agent and direct selling of Julphar products
  • SMS Pharmaceuticals, India (12.2%)
Julphar share capital, shares outstanding, AGM dates, dividends
  • 27 April 2008 - dividend record date
  • 17 April 2008 - AGM approved 10% cash & 5% share dividends
  • 31 March 2008 - AED 641,042,000 share capital (641.042 million shares outstanding) - 5% bonus shares (30.526 million) for 2007FY included
  • 31 December 2007 - AED 610,516,000 share capital
  • 31 March 2007 - AED 516,016,000 share capital
  • 31 December 2007 - AED 516,016,000 share capital
28 April 2008 - Julphar CEO
  • Abdul Razzak Yousef is listed as Chief Executive Officer (CEO) on 08Q1 balance sheet (& 07FY). Previously he was listed as the Managing Director. Unknown when change occured.
January 2008 - further capital increase and expansion plans
  • A report in Emirates Business said that Julphar would increase capital to AED 1 billion in a series of share issues from 2008-2010, at a price of 1.75 dhs per share (par value + 0.75 dhs premium).
  • Julphar expansion plans from 2008-2010 include investment of AED 1.2 billion in joint ventures towards construction of new plants in Afghanistan, Iran, Lebanon, Morocco, Sudan, Yemen.
  • Julphar is also expanding in Ras Al Khaimah with a reported 7 new plants opening there - two plants are scheduled to open in April 2008, three in 2009, and two in 2010.
  • Julphar also has expansion plans for, and agreements with companies in, Indonesia, Malaysia, the Philippines, Turkey. A previous report mentioned Bangladesh and India as other markets in which Julphar was setting up a prescence, or entering into supply and distribution agreements with local entities.
13 December 2007 - Planet Pharmacies

Julphar and Global Investment House (GLOBAL), a Kuwait based company with a secondary listing on the Dubai Financial Market, announced they would set up Planet Pharmacies LLC in Dubai, a holding company for a chain of retail outlets for pharmaceutical and healthcare products. They intend for Planet Pharmacies to be the largest chain in the Middle East. Initial operations will start with a reported (by the Khaleej Times) 65 pharmacies in the UAE and another 18 in Oman, expanding to about 2000 retail outlets by 2010. Initial capital would be AED 900 million, increasing to AED 3 billion, with a 40:60 ownership between Julphar and Global.

01 May 2007 - capital increase
  • A further 94,500,188 shares were issued to bring the total up to 610,516,188 shares outstanding from 516,016,000.
07 February 2007 - investment in India's SMS Pharmaceuticals

Julphar acquired a 12.2% equity stake in SMS Pharmaceuticals Ltd of India. SMS produces Ranitidine HCL and is an FDA approved manufacturer of Active Pharmaceutical Ingredients (API). Value of the deal was given as 300 million Rupees.

August 2006 - capital increase
  • Rights issue of 53,776,000 shares at par + 0.75 fils per share premium. Total shares outstanding 516,016,000
05 April 2006 - AGM approves capital increase and bonus shares
  • Shares outstanding increased from 385,200,000 to 462,240,000 shares via 20% share dividend
  • Capital increase of 537,760,000 dhs to take total capital to AED 1 billion
Contact details and investor informationTop
  • Julphar, PO Box 997, Ras Al Khaimah, UAE. Tel +971-7-2461461.
  • www.julphar.com - JULPHAR website home page.
  • julphar@emirates.net.ae - Julphar email.
JULPHAR - related external links (open in new window)Top
  • www.sca.ae - ESCA profile. Includes share ownership details, board of director names, meeting dates, financial statements and annual report.
  • www.adx.ae - ADX financial disclosures, news and information.

Disclaimer: ShareWadi.com and DubaiShareTalk.com provide UAE stockmarket related information, but do not offer investment advisory services, or brokerage services. Investing in shares is risky, you can lose some or all of your money and/or other assets. Anything you read on this site should be regarded as the opinion of the author only and is not to be taken as advice to buy, sell, or hold shares and/or other investments. Do not make investment decisions without due diligence and/or professional advice. In particular, do not assume anything you read on this site is correct or accurate. You should make your own investigations to determine if information is accurate and ultimately, you should accept that you and you alone are responsible for any investing decisions you make.

daily market reports | Calendar | Abu Dhabi Securities Exchange | Dubai Financial Market | ADSM DFM forms | Links | news & research | UAE IPO
RSS (daily market report) | DFM ADSM forum | FAQs | Dubai stock exchange | Contact Us | About Us | Terms of Service | Privacy Policy | Advertise

Copyright © ShareWadi.com 2005-2008. Any company names or product names used on this site, discussion forum, and/or communications from anyone associated with this website are the trademarks or registered trademarks of their respective holders.
This page last updated 26-Nov-2009. Company information last updated 24 Jun 2008. E & OE.